CorrespondenceUpdosing of secukinumab to every 2 weeks results in superior efficacy in patients with severe psoriasis weighing 90 kg or more: a real-world prospective observational study-Reference-Cited by-同舟云学术

CorrespondenceUpdosing of secukinumab to every 2 weeks results in superior efficacy in patients with severe psoriasis weighing 90 kg or more: a real-world prospective observational study

Published:2023-02-09 Issue:7 Volume:48 Page:793-812
ISSN:0307-6938
Container-title:Clinical and Experimental Dermatology
language:en
Short-container-title:

Author:

McGuire Niamh¹,Elamin Shahd²,Gough Pamela³,Cooke Nicola³,McGrath Conor¹,McKenna Kevin²,O’Kane Donal²

Affiliation:

1. Department of Dermatology, Southern Health and Social Care Trust , Portadown, Northern Ireland

2. Department of Dermatology, Belfast Health and Social Care Trust , Belfast, Northern Ireland

3. Department of Dermatology, South Eastern Health and Social Care Trust , Dundonald, Northern Ireland

Abstract

This is the first real-world prospective observational study demonstrating the superior efficacy of secukinumab dosing every 2 weeks in patients with severe psoriasis whose weight is > 90 kg.

Publisher

Oxford University Press (OUP)

Subject

Dermatology

Link

https://academic.oup.com/ced/advance-article-pdf/doi/10.1093/ced/llad035/50634720/llad035.pdf

Reference4 articles.

1. Secukinumab dosing optimization in patients with moderate-to-severe plaque psoriasis: results from the randomized, open-label OPTIMISE study;Reich;Br J Dermatol,2020

2. Effect of body weight on risk–benefit and dosing regimen recommendation of secukinumab for the treatment of moderate to severe plaque psoriasis;Lee;Clin Pharmacol Ther,2019

3. Secukinumab dosing every 2 weeks demonstrated superior efficacy compared with dosing every 4 weeks in patients with psoriasis weighing 90 kg or more: results of a randomized controlled trial;Augustin;Br J Dermatol,2022

4. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update;Smith;Br J Dermatol,2020